Home > Insider Trading > Filing (0001104659-12-007031)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314902	Colin Hislop	C/O Anthera Pharmaceuticals 25801 Industrial Blvd Suite B Hayward CA 94545	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-02-03	30,000	$8.20	27,967	No	4	S	Direct
Common Stock	Acquisiton	2012-02-06	9,923	$0.00	39,519	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	15,183	Indirect	By The Hislop-Burton Family Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2011.
Awards of Restricted Stock Units vest on the first anniversary of the grant date, with the grant date being February 6, 2012. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person until the Restricted Stock Units vest.
Not applicable.
Includes 1,629 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan on December 30, 2011.